Rockefeller Capital Management
NBP

Rockefeller Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Rockefeller Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-81
Closed – – 2904
2022
Q4 		$0 Hold
81
– – ﹤0.01% 4030
2022
Q3 		$0 Hold
81
– – ﹤0.01% 4117
2022
Q2 		$0 Hold
81
– – ﹤0.01% 4239
2022
Q1 		$1K Hold
81
– – ﹤0.01% 3741
2021
Q4 		$3K Sell
81
-89
-52% -$5.34K ﹤0.01% 3438
2021
Q3 		$12K Buy
+170
New +$12.3K ﹤0.01% 2798

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rockefeller Capital Management's NBP Position: Q1 2023 in Review

Rockefeller Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 81 shares.

Rockefeller Capital Management first reported a position in NBP in Q3 2021 and held it in 6 quarters. The position peaked at $12K in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

  • Rockefeller Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 81 NovaBridge Biosciences American Depositary Shares shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 6 quarters.
  • Rockefeller Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $12K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.